These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8847814)

  • 21. Gaucher disease.
    Mignot C; Gelot A; De Villemeur TB
    Handb Clin Neurol; 2013; 113():1709-15. PubMed ID: 23622393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gaucher disease: multiple lessons from a single gene disorder.
    Beutler E
    Acta Paediatr Suppl; 2006 Apr; 95(451):103-9. PubMed ID: 16720474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gaucher disease].
    Ohashi T
    Nihon Rinsho; 1995 Dec; 53(12):2943-6. PubMed ID: 8577040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current therapeutic focus in type I Gaucher's disease].
    Pérez Calvo JI; Pastores GM; Isola L; Giraldo P; Bueno Gómez J
    Sangre (Barc); 1994 Feb; 39(1):39-44. PubMed ID: 8197518
    [No Abstract]   [Full Text] [Related]  

  • 25. [Gaucher Disease].
    Okuyama T
    Brain Nerve; 2015 Sep; 67(9):1109-13. PubMed ID: 26329151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two novel mutations in glucocerebrosidase, C23W and IVS7-1 G>A, identified in Type 1 Gaucher patients heterozygous for N370S.
    Jack A; Amato D; Morris G; Choy FY
    Gene; 2014 Mar; 538(1):84-7. PubMed ID: 24434810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
    Hruska KS; LaMarca ME; Scott CR; Sidransky E
    Hum Mutat; 2008 May; 29(5):567-83. PubMed ID: 18338393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.
    Baris HN; Cohen IJ; Mistry PK
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1(0 1):72-81. PubMed ID: 25345088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gaucher disease: a heterogeneous clinical complex for which effective enzyme replacement has come of age.
    Frenkel EP
    Am J Med Sci; 1993 May; 305(5):331-44. PubMed ID: 8097903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.
    Beutler E; Gelbart T; Kuhl W; Sorge J; West C
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10544-7. PubMed ID: 1961718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations.
    Ida H; Rennert OM; Kawame H; Maekawa K; Eto Y
    J Inherit Metab Dis; 1997 Mar; 20(1):67-73. PubMed ID: 9061570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the beta-glucocerebrosidase gene in Czech and Slovak Gaucher patients: mutation profile and description of six novel mutant alleles.
    Hodanová K; Hrebícek M; Cervenková M; Mrázová L; Vepreková L; Zemen J
    Blood Cells Mol Dis; 1999; 25(5-6):287-98. PubMed ID: 10744424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocerebrosidase (Gaucher disease).
    Beutler E; Gelbart T
    Hum Mutat; 1996; 8(3):207-13. PubMed ID: 8889578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From gene to disease; Gaucher disease].
    Hollak CE; Boot RG; Poorthuis BJ; Aerts JM
    Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2163-6. PubMed ID: 16223076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a 55-bp deletion in the glucocerebrosidase gene in Gaucher disease: phenotypic presentation and implications for mutation detection assays.
    Mao R; O'Brien JF; Rao S; Schmitt E; Roa B; Feldman GL; Spence WC; Snow K
    Mol Genet Metab; 2001 Mar; 72(3):248-53. PubMed ID: 11243731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biochemical and genetic diagnosis of Gaucher disease and its phenotypical heterogeneity].
    Beĭer EM; Bukina TM; Tsvetkova IV
    Vopr Med Khim; 2000; 46(5):451-4. PubMed ID: 11204625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel insertion mutation in a non-Jewish Caucasian type 1 Gaucher disease patient.
    Choy FY; Humphries ML; Ferreira P
    Am J Med Genet; 1997 Jan; 68(2):211-5. PubMed ID: 9028460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
    Dandana A; Ben Khelifa S; Chahed H; Miled A; Ferchichi S
    Pathobiology; 2016; 83(1):13-23. PubMed ID: 26588331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease.
    McEachern KA; Nietupski JB; Chuang WL; Armentano D; Johnson J; Hutto E; Grabowski GA; Cheng SH; Marshall J
    J Gene Med; 2006 Jun; 8(6):719-29. PubMed ID: 16528760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.